Articles related to DIABETIC EYE DISEASE (DED)

A retrospective cohort study of 349,168 propensity-matched patients with diabetes found a hazard ratio of 2.22 for nonarteritic anterior ischemic optic neuropathy among semaglutide users compared with non-GLP-1 RA antidiabetic therapy users, with elevated risk emerging at two years and persisting through four years of follow-up.

Diabetic retinopathy is the only leading cause of blindness that has not experienced a decrease in age-standardized prevalence between 1990 and 2020, highlighting the urgent need for improved prevention and management strategies.

Autonomous AI at the point of care significantly increases diabetic retinopathy screening rates among young patients, addressing access gaps in underserved communities and offering a practical solution to improve patient outcomes.

In a significant advance for pediatric diabetes care, the introduction of the AI-based IDx-DR has doubled screening rates for diabetic retinopathy, underscoring the potential of technology to democratize healthcare access and eliminate racial bias in diagnostic processes.

This study provides compelling evidence that diabetes significantly alters the circadian rhythm of the transcriptomic profile in retinas. Such findings underscore the need for further research into this area, particularly given that diabetic retinopathy is a prevalent complication of diabetes.

Explore how an eyecare practice scaled its services for diabetic patients, achieving a 5% growth in this segment and setting a model for patient-centered, profitable care.